Cargando…
Efficacy and Safety of Levetiracetam vs. Phenobarbital for Neonatal Seizures: A Systematic Review and Meta-Analysis
Background: Neonatal seizures are a common neurological emergency in newborns. Phenobarbital (PB) is the first-line antiepileptic drug (AED). However, PB has some side effects, such as hypotension and respiratory depression, and it can accelerate neuronal apoptosis in the immature brain. Levetiracet...
Autores principales: | Qiao, Meng-Yuan, Cui, Hong-Tao, Zhao, Ling-Zhi, Miao, Jing-Kun, Chen, Qi-Xiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636327/ https://www.ncbi.nlm.nih.gov/pubmed/34867732 http://dx.doi.org/10.3389/fneur.2021.747745 |
Ejemplares similares
-
Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures
por: Maitre, Nathalie L, et al.
Publicado: (2013) -
A Comparative Study of Levetiracetam and Phenobarbital for Neonatal Seizures as a First Line Treatment
por: Akeel, Nagwa Elsayed, et al.
Publicado: (2022) -
Efficacy and safety of levetiracetam in the management of seizures in neonates
por: Sedighi, Mostafa, et al.
Publicado: (2016) -
Intravenous levetiracetam versus phenobarbital in children with status epilepticus or acute repetitive seizures
por: Lee, Yun-Jeong, et al.
Publicado: (2016) -
Efficacy of levetiracetam for neonatal seizures in preterm infants
por: Han, Ji Yoon, et al.
Publicado: (2018)